- Home
- SYPR vs ACRV Comparison
SYPR vs ACRV Comparison
Compare SYPR & ACRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYPR
- ACRV
- Stock Information
- Founded
- SYPR 1997
- ACRV 2018
- Country
- SYPR United States
- ACRV United States
- Employees
- SYPR N/A
- ACRV N/A
- Industry
- SYPR Industrial Machinery/Components
- ACRV Medicinal Chemicals and Botanical Products
- Sector
- SYPR Industrials
- ACRV Health Care
- Exchange
- SYPR Nasdaq
- ACRV Nasdaq
- Market Cap
- SYPR 44.1M
- ACRV 41.7M
- IPO Year
- SYPR 1994
- ACRV 2022
- Fundamental
- Price
- SYPR $1.92
- ACRV $1.35
- Analyst Decision
- SYPR
- ACRV Buy
- Analyst Count
- SYPR 0
- ACRV 7
- Target Price
- SYPR N/A
- ACRV $17.40
- AVG Volume (30 Days)
- SYPR 31.0K
- ACRV 253.4K
- Earning Date
- SYPR 08-12-2025
- ACRV 08-13-2025
- Dividend Yield
- SYPR N/A
- ACRV N/A
- EPS Growth
- SYPR N/A
- ACRV N/A
- EPS
- SYPR N/A
- ACRV N/A
- Revenue
- SYPR $130,040,000.00
- ACRV N/A
- Revenue This Year
- SYPR N/A
- ACRV N/A
- Revenue Next Year
- SYPR N/A
- ACRV $1,037.93
- P/E Ratio
- SYPR N/A
- ACRV N/A
- Revenue Growth
- SYPR N/A
- ACRV N/A
- 52 Week Low
- SYPR $1.30
- ACRV $1.05
- 52 Week High
- SYPR $3.72
- ACRV $10.16
- Technical
- Relative Strength Index (RSI)
- SYPR 42.86
- ACRV 53.72
- Support Level
- SYPR $1.91
- ACRV $1.20
- Resistance Level
- SYPR $2.03
- ACRV $1.32
- Average True Range (ATR)
- SYPR 0.07
- ACRV 0.09
- MACD
- SYPR -0.00
- ACRV 0.00
- Stochastic Oscillator
- SYPR 26.32
- ACRV 60.00
About SYPR Sypris Solutions Inc.
Sypris Solutions Inc is a USA-based company engaged in providing truck components, oil and gas pipeline components, and aerospace and defense electronics. The company offers a range of manufacturing, engineering, design, and other technical services. The business activity of the firm is functioned through Sypris Technologies and Sypris Electronics segments. Sypris Technologies segment is engaged in the sales of machined, welded, and heat-treated steel components for heavy commercial vehicle and high-pressure energy pipeline applications whereas the Sypris Electronics segment is engaged in the sale of manufacturing services, technical services, and products to customers in the market for aerospace and defense electronics. Sypris derives the revenue from the Technologies segment.
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.